As interest in using psychedelics to treat a range of mental health disorders grows, researchers consider the impact and therapeutic benefits of using psychedelics to help alleviate symptoms of depression.
DMT, a natural component of ayahuasca tea promotes neurogenesis, a new study reports. Researchers found DMT was capable of activating neural stem cells and promoted the formation of new neurons.
DMT alters electrical activity in the brain. The compound significantly decreases alpha wave activity, the dominant rhythm associated with wakefulness, and increases theta waves, associated with dreaming. Overall brain activity becomes more chaotic and less predictable. The findings advance the understanding of the neurobiological underpinnings of immersive states of consciousness.
DMT, an active compound of the psychedelic Ayahuasca, is naturally occurring in the mammalian brain, researchers have discovered. The study revealed DMT levels increased significantly in the rat visual cortex following cardiac arrest.
Researchers report DMT, the psychoactive compound of ayahuasca, can mimic actual near death experiences in healthy subjects.
Researchers explore the potential benefits of using hallucinogens for the treatment of PTSD, anxiety, depression and other mental health disorders.
Ayahuasca, a psychedelic drink made from Amazonian plants, may help relieve symptoms in those with treatment resistant depression, researchers report.
A new study reports people who have used a classic psychedelic are significantly less likely to commit a crime or indulge in criminal behavior. However, use of other controlled substances is linked to an increased risk of criminal behavior, researchers report.
Used in a controlled psychotherapy setting, psychedelics have the potential to treat psychiatric treatments that do not respond to conventional medications, researchers argue.
